On our anniversary episode, the P4A team discuss the USFDA approval of Novartis' Zolgensma, a one time gene therapy for paediatric spinal muscular atrophy patients and a look back at the last 12 months of our podcasting journey.
Presenter: Joanna Fernandes
Contributor: Christina Poschen, Aparna Krishnan
Producer: Aparna Krishnan
